Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacological Augmentation Strategies for Obsessive Compulsive Disorder Patients Non-respondent to First Line Medication Treatment: a Double Blind Placebo Controlled Study

NCT00466609 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT00466609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00466609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacological Augmentation Strategies for Obsessive Compulsive Disorder Patients Non-respondent to First Line Medication Treatment: a Double Blind Placebo Controlled Study
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2007
Completion date
April 30, 2010
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive compulsive disorder